Is 900 mg of Gabapentin a High Dose? Understanding Gabapentin Dosing
Author:
Blossom Editorial
A 900 mg daily dose of gabapentin is generally considered the lower end of the therapeutic dosing range, since the FDA-approved range for adults reaches up to 3,600 mg per day.
Gabapentin (brand name Neurontin) is an anticonvulsant medication approved to treat partial seizures and postherpetic neuralgia, a type of nerve pain that can follow shingles. It is also prescribed off-label for anxiety and sleep, which is where a lot of the confusion about dosing begins.
Whether 900 mg is high for you depends less on the number and more on the condition being treated, kidney function, and individual response.
Key Takeaways
900 mg per day is generally on the lower end of the therapeutic range for approved conditions: The FDA-approved starting regimen for partial seizures in children over 12 years and adults is 900 mg daily, divided into three 300 mg doses. The maximum studied dose in a small number of patients for a short term is 3,600 mg per day. For postherpetic neuralgia, doses start from 300 mg/day on Day 1, which is titrated to 900 mg/day on Day 3, and increased later as needed.
Gabapentin is almost always split across the day: Its short half-life of about 5 to 7 hours means a single 900 mg dose and three 300 mg doses behave very differently. How you take it matters as much as how much.
Kidney function is the biggest dose modifier: Gabapentin is cleared almost entirely by the kidneys. If your kidney function is reduced, 900 mg may act like a much higher dose, and your provider will lower it accordingly.
Is 900 mg of Gabapentin a High Dose? The Short Answer
No, not for most adults taking gabapentin for approved conditions. According to the FDA prescribing information for gabapentin (Neurontin), the recommended starting dose for postherpetic neuralgia in adults is 300 mg on Day 1 (single dose), 600 mg on Day 2 (two divided doses), and 900 mg on Day 3, given as three divided doses. For partial seizures, the effective range in adults is 900 mg to 1,800 mg per day, also divided into three doses.
In other words, 900 mg per day is where treatment typically begins for these approved conditions. Doses can be titrated up to 1,800 mg per day for nerve pain and can be taken up to 3,600 mg per day for seizures, though studies on higher doses are limited to a short duration.
That said, 900 mg is not a small amount of medication, and for someone new to gabapentin or someone with reduced kidney function, it can feel like a lot more.
Gabapentin Dosing Guidelines: The Full Range
Gabapentin dosing looks unusual compared with most psychiatric medications, because the numbers are large and the range is wide. Here is how it breaks down.
Starting Doses
Gabapentin is typically prescribed at an initial dose of 300 mg/day (nerve pain) or 300 mg three times per day (partial seizures) and is gradually titrated upwards.
The slow start exists for a reason: dizziness and drowsiness are most pronounced in the first days and tend to ease as your body adjusts. Providers treating anxiety off-label may also start at 300 mg three times daily and increase gradually as required.
Therapeutic Range for Adults
For postherpetic neuralgia, the label describes 900 mg to 1,800 mg per day in three divided doses and notes that doses above 1,800 mg did not show added benefit in trials. For partial seizures, the effective range for a maintenance dose is 900 mg to 1,800 mg per day given in three divided doses, with the maximum studied dose at 3,600 mg per day.
However, while doses of 2,400 mg per day have been shown to be tolerated in long-term clinical studies, the highest dose of 3,600 mg per day has been studied only in a limited number of patients and only over a short term.
Why Gabapentin is Divided Into Three Doses
Gabapentin has an elimination half-life of roughly 5 to 7 hours, which is short. The label also specifies that the interval between doses should not exceed 12 hours. Taking 900 mg all at once would produce a high peak in blood levels, followed by a long stretch when blood levels are too low to maintain a therapeutic response. Dividing doses helps maintain relatively stable levels of the medication in the blood throughout the day, providing a consistent therapeutic effect.
There is another reason. Gabapentin absorption is not proportional to dose. As the amount in a single dose rises, the percentage your body actually absorbs falls. Splitting doses works around this.
Is 900 mg of Gabapentin a High Dose for Anxiety?
This is where the answer is more subjective. Gabapentin is not FDA-approved for any anxiety disorder, so there is no official dosing guidance to compare against. Studies have used doses ranging from about 900 mg to 3600 mg per day, although many clinicians prescribe lower doses.
However, the evidence for the use of gabapentin in anxiety is thinner than many people assume. A systematic review and meta-analysis from 2021 examining gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia concluded that while the evidence for gabapentinoids in bipolar disorder and insomnia is limited, gabapentin produced a moderate effect size across the anxiety spectrum.
The same study noted that gabapentin showed a dose-dependent anxiolytic (anti-anxiety) effect on preoperative anxiety, with a minimum dose of 600 mg (single dose) producing a significant response.
A 2012 randomized, controlled trial of gabapentin for eight weeks in 420 breast cancer survivors showed significant improvement in anxiety scores, and a smaller, placebo-controlled trial in people with social anxiety disorder showed improved symptoms after 14 weeks. However, gabapentin failed to produce an effective response compared to placebo in another trial involving people with panic disorder.
A separate systematic review of gabapentin in psychiatric disorders found it may benefit some anxiety conditions, including social anxiety, while noting that no trials exist for generalized anxiety disorder specifically.
That does not mean gabapentin cannot help with anxiety. It means the research base is narrower than the prescribing volume would suggest.
Presently, gabapentin is more commonly used in cases where patients haven’t responded well to conventional anxiety medications, including antidepressants and benzodiazepines, or as adjunctive treatment alongside conventional antidepressant medication.
How Kidney Function Changes What Counts as High
Gabapentin is not broken down by the liver at all. It is excreted unchanged by the kidneys, which makes kidney function the single most important variable in dosing.
The FDA label specifies dose adjustments based on creatinine clearance, a measure of kidney filtering. For people with reduced kidney function, the recommended daily dose can drop substantially, and for those on dialysis, dosing is tied to the dialysis schedule.
Older adults often have reduced kidney function even without a diagnosed kidney problem, which is why the label advises starting at the low end of the range in this group.
The practical takeaway: 900 mg per day may be a starting dose for one person and a genuinely high dose for another, based entirely on how well their kidneys clear it.
Side Effects of Gabapentin at 900 mg
Side effects are generally dose-related, meaning they tend to increase as the daily total rises.
Common Side Effects
Dizziness, drowsiness, unsteadiness or trouble with coordination, fatigue, swelling in the hands or feet (edema), blurred or double vision, diarrhea, and dry mouth are the most frequently reported. Most side effects are worse during the first week or two and improve as your body adapts.
Driving and Daily Function
The FDA label warns that gabapentin may cause significant driving impairment and that people are not always good judges of their own impairment while taking it. Do not drive until you know how the medication affects you, and be especially careful after any dose increase.
Combining Gabapentin With Other Sedating Medications
This is the most serious safety issue. Gabapentin has been linked to life-threatening respiratory depression when combined with opioids or other central nervous system depressants, or in people with existing breathing problems. If you take an opioid, a benzodiazepine, or anything sedating, your provider needs to know before adding gabapentin.
Can You Stop Gabapentin at 900 mg?
Not abruptly. In 2025, the FDA required labeling updates for gabapentinoid products to reflect the risk of discontinuation symptoms. The label describes postmarketing reports of symptoms after abrupt discontinuation, including anxiety, depression, insomnia, nausea, pain, tremor, and sweating, along with more serious reports such as seizures, agitation, suicidal ideation, and disorientation. The risk of symptoms is higher in cases of abrupt discontinuation following prolonged use or higher doses.
For people taking gabapentin for seizures, abrupt discontinuation can increase seizure frequency. The label recommends withdrawing gradually over a minimum of one week. In practice, providers often go slower.
Misuse and Dependence: What the Research Shows
Gabapentin is not a federally controlled substance in the United States, though several states have scheduled it. It was originally thought to have relatively low abuse potential, and that assumption has softened.
A systematic review of gabapentin misuse, abuse, and diversion found that misuse is concentrated among people with a history of substance use disorder, particularly opioid use. Prevalence of intentional misuse in the general public appears low at 1%, while rates among people who misuse opioids are considerably higher at 15-22%.
For most people taking prescription gabapentin as directed, this is not a significant concern, but it is worth having an honest conversation with a provider for those with a history of substance misuse. For people with concerns about misuse, safer, non-addictive anxiety medications are available.
When to Seek Medical Attention
Contact your provider promptly if you experience severe drowsiness or difficulty waking, slowed or shallow breathing, a rash with fever or swollen glands, or new or worsening thoughts of self-harm. Gabapentin has been associated with a rare but serious hypersensitivity reaction affecting multiple organs, and any rash that appears with systemic symptoms deserves urgent evaluation.
Sudden confusion, unsteadiness that is getting worse rather than better, or swelling that spreads also warrants a same-day call. If you are having thoughts of hurting yourself, call or text 988 to reach the Suicide and Crisis Lifeline.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Always talk with your physician or another qualified healthcare provider about any questions you have regarding a medical condition or medication, and never stop or change a prescription without guidance. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Sources
U.S. Food and Drug Administration. (2025). Neurontin (gabapentin) capsules, tablets, and oral solution: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020235s079,020882s060,021129s059lbl.pdf
Yasaei R, Katta S, Patel P, et al. Gabapentin. [Updated 2024 Feb 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493228/
U.S. Food and Drug Administration. (2025). Supplement approval letter for Neurontin (gabapentin) (NDA 020235/S-079, NDA 020882/S-060, NDA 021129/S-059). https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/020235Orig1s079,%20020882Orig1s060,%20021129Orig1s059ltr.pdf
Hong, J. S. W., Atkinson, L. Z., Al-Juffali, N., Awad, A., et al. (2022). Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Molecular psychiatry, 27(3), 1339–1349. https://pmc.ncbi.nlm.nih.gov/articles/PMC9095464/
Lavigne, J. E., Heckler, C., Mathews, J. L., et al. (2012). A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors. Breast cancer research and treatment, 136(2), 479–486. https://pubmed.ncbi.nlm.nih.gov/23053645/
Pande, A. C., Davidson, J. R., Jefferson, J. W., et al. (1999). Treatment of social phobia with gabapentin: a placebo-controlled study. Journal of clinical psychopharmacology, 19(4), 341–348. https://pubmed.ncbi.nlm.nih.gov/10440462/
Pande, A. C., Pollack, M. H., Crockatt, J., Greiner, M., Chouinard, G., Lydiard, R. B., Taylor, C. B., Dager, S. R., & Shiovitz, T. (2000). Placebo-controlled study of gabapentin treatment of panic disorder. Journal of clinical psychopharmacology, 20(4), 467–471. https://pubmed.ncbi.nlm.nih.gov/10917408/
Berlin, R. K., Butler, P. M., Perloff, M. D. Gabapentin Therapy in Psychiatric Disorders: A Systematic Review. The Primary Care Companion for CNS Disorders. https://pmc.ncbi.nlm.nih.gov/articles/PMC4732322/
Smith, R. V., Havens, J. R., & Walsh, S. L. (2016). Gabapentin misuse, abuse and diversion: a systematic review. Addiction (Abingdon, England), 111(7), 1160–1174. https://pmc.ncbi.nlm.nih.gov/articles/PMC5573873/
Greenblatt, H.K., Greenblatt, D. J. (2018). Gabapentin and Pregabalin for the Treatment of Anxiety Disorders. Clinical Pharmacology in Drug Development, 7(3), 228-232. https://accp1.onlinelibrary.wiley.com/doi/10.1002/cpdd.446
Ahmed, S., Bachu, R., Kotapati, P., et al. Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review. Frontiers in Psychiatry. https://pmc.ncbi.nlm.nih.gov/articles/PMC6514433/
Hamer, A. M., Ambizas, E. M. Psychiatric Uses of Gabapentin. Innovations in Clinical Neuroscience. https://pmc.ncbi.nlm.nih.gov/articles/PMC9507147/
National Institute of Mental Health. (2024, December). Anxiety disorders. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/topics/anxiety-disorders
